Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Other financing activities (2016 - 2025)

Historic Other financing activities for AC Immune (ACIU) over the last 11 years, with Q3 2025 value amounting to $205012.2.

  • AC Immune's Other financing activities rose 10564.77% to $205012.2 in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.0 million, marking a year-over-year increase of 1623.07%. This contributed to the annual value of -$6566.1 for FY2021, which is N/A changed from last year.
  • AC Immune's Other financing activities amounted to $205012.2 in Q3 2025, which was up 10564.77% from $478267.7 recorded in Q1 2025.
  • In the past 5 years, AC Immune's Other financing activities registered a high of $8.5 million during Q1 2021, and its lowest value of -$13.4 million during Q4 2021.
  • Its 5-year average for Other financing activities is -$292048.4, with a median of -$142246.1 in 2022.
  • Per our database at Business Quant, AC Immune's Other financing activities soared by 329121.39% in 2021 and then crashed by 81568.44% in 2024.
  • Over the past 5 years, AC Immune's Other financing activities (Quarter) stood at -$13.4 million in 2021, then soared by 98.9% to -$147034.8 in 2022, then surged by 444.96% to $507204.3 in 2023, then crashed by 815.68% to -$3.6 million in 2024, then surged by 105.65% to $205012.2 in 2025.
  • Its Other financing activities was $205012.2 in Q3 2025, compared to $478267.7 in Q1 2025 and -$3.6 million in Q3 2024.